Helen H. Lu | |
---|---|
Alma mater | University of Pennsylvania (BS, PhD) |
Scientific career | |
Fields | Tissue engineering |
Institutions | Fu Foundation School of Engineering and Applied Science |
Thesis | 45S5 bioactive glass surface zeta potential variations in electrolyte solutions with and without fibronectin (1998) |
Doctoral advisor | Solomon R. Pollack Paul Ducheyne |
Helen Haiyan Lu is a Chinese American biomedical engineer and the Percy K. and Vida L. W. Hudson professor of biomedical engineering at the Columbia University Fu Foundation School of Engineering and Applied Science. [1] Her work focuses on understanding and developing therapies in complex tissue systems, especially the interface between soft tissue and bone.
Lu studied bioengineering at the University of Pennsylvania for her undergraduate and doctoral degrees. [2] [3] Her thesis focused on characterization of bioactive glasses. Lu completed postdoctoral fellowships with Cato T. Laurencin at Drexel University (1998-00) and David Kaplan at Tufts University (2001). [4] [5]
Lu has been a faculty member at Columbia since 2001, where she directs the biomaterials and interface tissue engineering laboratory. She has been a full professor in biomedical engineering since 2014, and has also held appointments in the department of dental and craniofacial bioengineering. [1] Lu is a member of the Tissue Engineering and Regenerative Medicine International Society American continental council. [6]
Her work in regenerative engineering includes developing scaffolds for stem cell growth, for which she was honored by Presidential Early Career Award in 2010. [7] In 2011, Lu was elected a Fellow of the American Institute for Medical and Biological Engineering. [7]
Lu has studied biomaterials for regeneration of tendons and ligaments extensively, focusing on bioinspired approaches. In particular, her recent research has focused on rotator cuff repair, although potential applications extend to any soft tissue-bone interface repairs. [8] [9] Lu has said that integrative tissue engineering will eventually "pave the way for total limb regeneration." [10]
A biomaterial is a substance that has been engineered to interact with biological systems for a medical purpose – either a therapeutic or a diagnostic one. The corresponding field of study, called biomaterials science or biomaterials engineering, is about fifty years old. It has experienced steady growth over its history, with many companies investing large amounts of money into the development of new products. Biomaterials science encompasses elements of medicine, biology, chemistry, tissue engineering and materials science.
Peter W. Zandstra, is a Canadian scientist who is the Director of the Michael Smith Laboratories at the University of British Columbia.
Ali Khademhosseini is the CEO of the Terasaki Institute, non-profit research organization in Los Angeles, and Omeat Inc., a cultivated-meat startup. Before taking his current CEO roles, he spent one year at Amazon Inc. Prior to that he was the Levi Knight chair and professor at the University of California-Los Angeles where he held a multi-departmental professorship in Bioengineering, Radiology, Chemical, and Biomolecular Engineering as well as the Director of Center for Minimally Invasive Therapeutics (C-MIT). From 2005 to 2017, he was a professor at Harvard Medical School, and the Wyss Institute for Biologically Inspired Engineering.
Cato T. Laurencin FREng SLMH is an American engineer, physician, scientist, innovator and a University Professor of the University of Connecticut.
Nick Rhodes is a Reader in Tissue Engineering and Regenerative Medicine at the University of Liverpool, in the U.K. Tissue Engineering can be described as the use of engineering techniques, including engineering materials and processes, in order to grow living tissues. Regenerative Medicine can be described as the treatment of defective tissues using the regenerative capacity of the body's healthy tissues. Rhodes describes the discipline as "aiming to repair tissue defects by driving regeneration of healthy tissues using engineered materials and processes."
Kristi S. Anseth is the Tisone Distinguished Professor of Chemical and Biological Engineering, an Associate Professor of Surgery, and a Howard Hughes Medical Investigator at the University of Colorado at Boulder. Her main research interests are the design of synthetic biomaterials using hydrogels, tissue engineering, and regenerative medicine.
Gordana Vunjak-NovakovicFRSC is a Serbian American biomedical engineer and university professor. She is a University Professor at Columbia University, as well as the Mikati Foundation Professor of Biomedical Engineering and Medical Sciences. She also heads the laboratory for Stem Cells and Tissue Engineering at Columbia University. She is part of the faculty at the Irving Comprehensive Cancer Center and the Center for Human Development, both found at Columbia University. She is also an honorary professor at the Faculty of Technology and Metallurgy at the University of Belgrade, an honorary professor at the University of Novi Sad, and an adjunct professor at the Department of Biomedical Engineering at Tufts University.
Tissue Engineering and Regenerative Medicine International Society is an international learned society dedicated to tissue engineering and regenerative medicine.
Rui Luís Reis is a Portuguese scientist known for his research in tissue engineering, regenerative medicine, biomaterials, biomimetics, stem cells, and biodegradable polymers.
Ravi V. Bellamkonda is an Indian-American biomedical engineer and academic administrator. Since 2021, he has served as Provost and Executive Vice President for Academic Affairs at Emory University in Atlanta, Georgia. Bellamkonda was previously Vinik Dean of the Pratt School of Engineering at Duke University.
Molly S. Shoichet, is a Canadian science professor, specializing in chemistry, biomaterials and biomedical engineering. She was Ontario's first Chief Scientist. Shoichet is a biomedical engineer known for her work in tissue engineering, and is the only person to be a fellow of the three National Academies in Canada.
Anthony Steven Weiss AM PhD FRSC FTSE FRSN FRACI, FTERM, FBSE is a university researcher, company founder and entrepreneur. He is the leading scientist in human tropoelastin research and synthetic human elastin. He holds the McCaughey Chair in Biochemistry, heads the Charles Perkins Centre Node in Tissue Engineering and Regenerative Medicine, and is Professor of Biochemistry and Molecular Biotechnology at the University of Sydney. His discoveries are on human elastic materials that accelerate the healing and repair of arteries, skin and 3D human tissue components. He is a Fellow of the Royal Society of Chemistry. Weiss is on the editorial boards of the American Chemical Society Biomaterials Science and Engineering, Applied Materials Today (Elsevier), Biomaterials, Biomedical Materials, BioNanoScience (Springer) and Tissue Engineering. He is a biotechnology company founder, promoter of national and international technology development, and has received national and international awards, including the Order of Australia.
Alan J. Russell, is Vice President of Biologics for Amgen, one of the world’s leading Biopharmaceutical companies. Until 2020, Alan was the Highmark Distinguished Career Professor and Director of the Disruptive Health Technology Institute at Carnegie Mellon University. From 2013 through spring of 2016 he was also the Chief Innovation Officer, Allegheny Health Network.
Treena Livingston Arinzeh is an American biomedical engineer and academic.
The Institute for Bioengineering of Catalonia (IBEC) is an institution engaged in basic and applied research in bioengineering and nanomedicine, with experts working on tissue regeneration, biomechanics, molecular dynamics, biomimetics, drug delivery, organs ‘on-a-chip’, cell migration, stem cells, artificial olfaction and microbial biotechnology. The institute was created by the Government of Catalonia, the University of Barcelona and the Polytechnic University of Catalonia in December 2005 and is located at the Barcelona Science Park. The director of the institute is Prof. Josep Samitier, who took over from founding director Josep A. Planell i Estany in 2013. In 2014 IBEC was named a "Severo Ochoa Centre of Excellence" by the Spanish Ministry of Economy and Competitiveness.
Antonios Georgios Mikos is a Greek-American biomedical engineer who is the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University. He specialises in biomaterials, drug delivery, and tissue engineering.
Jennifer Hartt Elisseeff is an American biomedical engineer, ophthalmologist and academic. She is the Morton Goldberg Professor and Director of the Translational Tissue Engineering Center at Johns Hopkins Department of Biomedical Engineering and the Wilmer Eye Institute with appointments in Chemical Engineering, Biomedical Engineering, Materials Science and Orthopedic Surgery. Elisseeff's research is in the fields of regenerative medicine and immunoengineering.
Akhilesh K. Gaharwar is an Indian academic and a professor in the Department of Biomedical Engineering at Texas A&M University. The goal of his lab is to understand the cell-nanomaterials interactions and to develop nanoengineered strategies for modulating stem cell behavior for repair and regeneration of damaged tissue.
Tatiana Segura is an American biomedical engineer who is a professor at Duke University. Her research considers biomedical engineering solutions to promote cell growth. She was elected Fellow of the American Institute for Medical and Biological Engineering in 2017 and awarded the Acta Biomaterialia Silver Medal in 2021.
Karen Leigh Christman is an American bioengineer who is the Associate Dean for Faculty Affairs and the Pierre Galletti Endowed Chair for Bioengineering Innovation at University of California, San Diego. Her research considers regenerative medicine and tissue engineering. She was elected a Fellow of the National Academy of Inventors in 2023.